Find participating medical centers and current study status in each of them
Find participating medical centers
-
Home
-
Clinical Study Finder
- LAUREL
A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis (UC) Participants Who Are Naive to Tumor Necrosis Factor (TNF) Inhibitors
-
Autoimmune Disorder -
Inflammatory Bowel Disease (IBD) -
Ulcerative Colitis
- Results
-
Download -
Study results
LPS GA29102 LAUREL Interim Results October 2021 English
(PDF, 0.6 MB)
LPS GA29102 LAUREL Final Results November 2021 Czech
(PDF, 0.4 MB)
LPS GA29102 LAUREL Final Results November 2021 Danish
(PDF, 0.4 MB)
LPS GA29102 LAUREL Final Results November 2021 German
(PDF, 0.4 MB)
LPS GA29102 LAUREL Final Results November 2021 Spanish
(PDF, 0.3 MB)
LPS GA29102 LAUREL Final Results November 2021 French
(PDF, 0.4 MB)
LPS GA29102 LAUREL Final Results November 2021 Hebrew
(PDF, 0.4 MB)
LPS GA29102 LAUREL Final Results November 2021 Hungarian
(PDF, 0.4 MB)
LPS GA29102 LAUREL Final Results November 2021 Italian
(PDF, 0.3 MB)
LPS GA29102 LAUREL Final Results November 2021 Polish
(PDF, 0.4 MB)
LPS GA29102 LAUREL Final Results November 2021 Portugese
(PDF, 0.4 MB)
LPS GA29102 LAUREL Final Results November 2021 Slovak
(PDF, 0.4 MB)
LPS GA29102 LAUREL Final Results November 2021 Ukrainian
(PDF, 0.4 MB)
LPS GA29102 LAUREL Final Results October 2021 Indian
(PDF, 0.5 MB)
Explore related studies
For the latest version of this information please go to www.forpatients.roche.com